Controllability of a model of combined anticancer therapy
From MaRDI portal
Publication:5500976
zbMATH Open1318.93020MaRDI QIDQ5500976FDOQ5500976
Authors: Jerzy Klamka, Andrzej Świerniak 
Publication date: 10 August 2015
Recommendations
- Local controllability of models of combined anticancer therapy with delays in control
- Local controllability and optimal control for a model of combined anticancer therapy with control delays
- Constrained bilinear control problem: application to a cancer chemotherapy model
- scientific article; zbMATH DE number 4112436
- An optimal control problem in cancer chemotherapy
Cited In (10)
- Global stability and tumor clearance conditions for a cancer chemotherapy system
- Mixed therapy in cancer treatment for personalized drug administration using model reference adaptive control
- Local controllability of models of combined anticancer therapy with delays in control
- Robust feedback design for combined therapy of cancer
- Finite-time fuzzy reliable controller design for fractional-order tumor system under chemotherapy
- Null controllability of a nonlinear dissipative system and application to the detection of the incomplete parameter for a nonlinear population dynamics model
- Controllability of hybrid PDE-ODE systems with structural instability and applications to mathematical models on intermittent hormonal therapy for prostate cancer
- Local controllability and optimal control for a model of combined anticancer therapy with control delays
- Optimal control strategy for cancer remission using combinatorial therapy: a mathematical model-based approach
- Constrained control approach for monotone systems: application to tumour chemotherapy
This page was built for publication: Controllability of a model of combined anticancer therapy
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5500976)
